RYAH Group, engaged in the development and commercialization of various innovative technology solutions for the plant-based medical industry, was featured in The Bell2Bell Podcast, a part of InvestorBrandNetwork’s (“IBN”) sustained effort to provide specialized content distribution via widespread syndication channels. RYAH’s CEO Gregory Wagner joined the latest episode to discuss the company’s 2021 goals and milestones, as well as provide an overview of RYAH’s business model and product offerings. “I came to the company two years ago, and the reason why I came here from a different career was because I was completely floored by the amount of data this company had been collecting over years in plant-based medicine,” Wagner said. “Essentially the company’s mission is both devices and data. I like to think of the company as a pioneering IoT device and digital care platform. We’re designed to capture complex datapoints to better enable doctors and clinics to create highly customized, personalized dosing regiments… and also to help governments make better regulatory decisions around plant-based medicine based on the data that we can provide and hopefully, eventually, encourage Big Pharma to make medical breakthroughs in plant-based medicine with our data analytics.”
To view the full press release, visit https://ibn.fm/WbWK2
About RYAH Group Inc.
RYAH is a company operating out of New York, which, directly and through its wholly owned subsidiary RYAH Medtech Inc., is engaged in the development and commercialization of various innovative technology solutions (both software and hardware) for the plant-based medical industry. Since its formation, RYAH Group has been focused on leveraging its know-how in predictive analytics to pioneer products to be used within its suite of vertically integrated technologies to provide users with added control over their health and wellness. As an emerging company, RYAH is striving to establish itself as a leader in delivering innovative, user-friendly IoT devices in the plant-based medical industry. By utilizing its know-how in fields such as artificial intelligence and predictive analytics, the company is moving towards building a portfolio of vertically integrated products that facilitate harmonized data collection throughout the complete medical plant lifecycle, from seed to consumption. For more information about the company, please visit www.RYAHGroup.com.
NOTE TO INVESTORS: The latest news and updates relating to RYAH Group are available in the company’s newsroom at https://ibn.fm/RYAH
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment